| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 04/01/2008 | US7351697 Tumor-specific vector for gene therapy |
| 04/01/2008 | US7351694 Diagnosis of prostate cancer; genetic engineered protein |
| 04/01/2008 | US7351585 Retroviral vector |
| 04/01/2008 | US7351577 For hemophilia gene therapy |
| 04/01/2008 | US7351428 Phosphatidyl oligoglycerols |
| 04/01/2008 | US7351415 Gene therapy; vaccines; storage stability; mixture containing viruses |
| 04/01/2008 | CA2305623C Porcine circovirus, vaccines, and diagnostic reagents |
| 04/01/2008 | CA2291074C Composition and method for enhancing transport across biological membranes |
| 04/01/2008 | CA2175992C In situ modification and manipulation of stem cells of the central nervous system |
| 03/27/2008 | WO2008036953A2 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
| 03/27/2008 | WO2008036933A2 Compositions and methods for inhibiting expression of the hamp gene |
| 03/27/2008 | WO2008036929A2 Complex for transferring an anionic substance into a cell |
| 03/27/2008 | WO2008036867A2 Methods for treatment of inflammatory disease and chlamydia infectious disease |
| 03/27/2008 | WO2008036638A2 Rnai modulation of scap and therapeutic uses thereof |
| 03/27/2008 | WO2008035692A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 03/27/2008 | WO2008034637A1 Methods involving lef-1 regulation and use of lef-1 or compounds altering lef-1 signalling for treating or preventing diseases |
| 03/27/2008 | WO2008034608A1 The death receptor cd95 controls neurogenesis of adult neural stem cells in vivo and in vitro |
| 03/27/2008 | WO2008034388A1 Virus-like particles of capsid proteins from human papillomavirus type 16/58/18/6/11 and the method for preparation and the uses thereof |
| 03/27/2008 | WO2007135570A3 Pink1 deficient animals, screening methods, and related therapeutics |
| 03/27/2008 | WO2007122369A3 Novel tumour suppressor |
| 03/27/2008 | WO2006065960A3 Cationic liposomes comprising a charge neutral compound and a cationic phospholipid |
| 03/27/2008 | WO2001022921A3 Prevention of atherosclerosis and undesired blood clotting by reducing von willebrand factor |
| 03/27/2008 | US20080076906 Antagonists of neuropilin receptor function and use thereof |
| 03/27/2008 | US20080076732 Gene expression control DNA element and associated protein |
| 03/27/2008 | US20080076731 Control of NK cell function and survival by modulation of ship activity |
| 03/27/2008 | US20080076713 Peptides selectively lethal to malignant and transformed mammalian cells |
| 03/27/2008 | US20080076709 Isolated polypeptide, encoded by nucleic acid sequence, a vector from Staphylococcus; use for activators or inhibitors in therapy, antigen for vaccination, antibodies; antibacterial agent treating Staphylococcus infections; biodrugs |
| 03/27/2008 | US20080076704 Delivering therapeutic formulation containing N-sulphated-N,O-carboxymethylchitosan as a primary carrier across a membrane that has limited permeability for therapeutic agent |
| 03/27/2008 | US20080076175 Generating transgenic lymphoid cell comprising sequences coding immunoglobulin epitope for use in tissue targeted therapies |
| 03/27/2008 | US20080076173 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 03/27/2008 | US20080076172 Vectors for tissue-specific replication |
| 03/27/2008 | US20080075763 Polycationic sterol derivatives as transfection agents |
| 03/27/2008 | US20080075740 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor |
| 03/27/2008 | US20080075739 Attenuated Salmonella SP12 Mutants as Antigen Carriers |
| 03/27/2008 | US20080075737 inducing an immune response to an HIV antigen; genetic engineered polypeptide; inserted into cell; improves or restores the blood clotting time, blood disorders; gene therapy |
| 03/27/2008 | US20080075713 isomerase enzymes and ATP-binding cassette (ABC) transport proteins, used for controlling metabolism of triglycerides; diagnosis, prevention and treatment of metabolic disorders |
| 03/27/2008 | US20080075703 using a mixture of cells including connective tissue cells transfected or transduced with genes encoding transforming growth factors or bone morphogenic proteins, used for regenerating cartilage and treatment of osteoarthritis; somatic cell gene therapy; tissue-targeted therapy |
| 03/27/2008 | US20080075701 a mixture of magnetic nanoparticles and nucleic acids, transfected gene, deoxyribonucleic acids and/or ribonuecleic acids, encapsulated in hydrophilic liposomes; transfection efficiency to cells |
| 03/27/2008 | US20080075657 Forming a biocompatible hydrogel in situ; adding a liquid premix of alkylated chitosan and an oxidized polysaccharide in an aqueous medium into an intervertebral disc, hydrogel induces tissue growth within the disc |
| 03/27/2008 | CA2700360A1 In vivo transformation of pancreatic acinar cells into insulin-producing cells |
| 03/27/2008 | CA2663819A1 Phytases, nucleic acids encoding them and methods for making and using them |
| 03/26/2008 | EP1903107A1 Pluripotent embryonic-like stem cells, compositions, methods and uses thereof |
| 03/26/2008 | EP1903068A1 Biodegradable poly(beta-amino esters) and uses thereof |
| 03/26/2008 | EP1903057A2 Lipoprotein-regulating medicaments |
| 03/26/2008 | EP1903054A2 Pharmaceutical compound containing a stabilised mRNA which is optimised for translation in its coded areas |
| 03/26/2008 | EP1902729A1 Int6 PROTEIN INVOLVED IN HYPOXIA STRESS INDUCTION AND USE THEREOF |
| 03/26/2008 | EP1902318A1 Methods for identifying fzd8 modulators and the use of such modulators for treating osteoarthritis |
| 03/26/2008 | EP1901768A1 Methods of modulating il-23 activity; related reagents |
| 03/26/2008 | CN101151371A Retrotransposon inhibition in therapy |
| 03/26/2008 | CN101151274A ROR alpha for promoting the induction of Bmal1 expression |
| 03/26/2008 | CN101151272A Recombinant icosahedral virus like particle production in pseudomonads |
| 03/26/2008 | CN101148681A Targeted coexpression p53 and Mda-7 recombination adenovirus |
| 03/26/2008 | CN101148680A Method for leading plasmid carrier containing gene cure segment in cell by nano particles |
| 03/26/2008 | CN101148667A Preparation and use for affinity human albumin nucleic acid aptamer |
| 03/26/2008 | CN101148666A Nucleic acid aptamer with high specificity and high affinity to human breast carcinoma tissue, preparation method and application thereof |
| 03/26/2008 | CN101148661A Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 03/26/2008 | CN101148473A Recombination human insulin and its coding gene and application |
| 03/26/2008 | CN101148472A Tumour inhibitory gene or protein and application thereof |
| 03/26/2008 | CN101148467A Oligonucleotide and use thereof for treating lung cancer |
| 03/26/2008 | CN101148466A RNA disturbance target point for inhibiting MDV proliferating and application thereof |
| 03/26/2008 | CN101147807A Substances for preventing and treating autoimmune diseases |
| 03/26/2008 | CN100376680C Dual target effected chimera recombinant, its construction method and application |
| 03/26/2008 | CN100376594C Double-chain RNA and method for initiate, enhance or adjust immunomodulatory of immune response |
| 03/25/2008 | US7348453 Complexing using an ortho carboxy acetal |
| 03/25/2008 | US7348410 Flea head, nerve cord, hindgut and malpighian tubule proteins |
| 03/25/2008 | US7348406 Administering a polypeptide or biologically active fragment; reducing body mass; metabolic-related diseases, hyperlipidemias, atherosclerosis, diabetes, and hypertension |
| 03/25/2008 | US7348178 Recombinant adenoviral vector system |
| 03/25/2008 | US7348177 Expression of HIV polypeptides and production of virus-like particles |
| 03/25/2008 | US7348148 Polynucleotide analog with polyether, polythioether, polyether sulfone, and/or and polyether sulfoxide linkages; antisense drug therapy |
| 03/25/2008 | US7348138 Diagnostic methods and kits for identifying individuals exposed to West Nile virus or other viruses including Flavivirus or Pestivirus |
| 03/25/2008 | US7348015 Antigen modified cancer cell vaccines for cancer therapy |
| 03/25/2008 | US7348014 Anticancer agents; gene therapy; trimers; host cells; genomes |
| 03/25/2008 | US7347998 Method of delivering therapeutic agents to site of tissue injury |
| 03/25/2008 | CA2243578C High affinity nucleic acid ligands of complement system proteins |
| 03/25/2008 | CA2203652C A method of down-regulating gene expression |
| 03/25/2008 | CA2189984C P75 tnf receptor promoters |
| 03/25/2008 | CA2073500C Compositions and methods for detecting and modulating rna activity and gene expression |
| 03/20/2008 | WO2008034123A2 Polymeric conjugates containing positively-charged moieties |
| 03/20/2008 | WO2008034122A2 Hindered ester-based biodegradable linkers for oligonucleotide delivery |
| 03/20/2008 | WO2008034120A2 Lysine-based polymeric linkers |
| 03/20/2008 | WO2008033403A2 Agents and methods to elicit anti-tumor immune response |
| 03/20/2008 | WO2008033374A2 Ocl-2a3 compositions and uses thereof |
| 03/20/2008 | WO2008033304A2 Compositions for promoting non-leaky collateral vascularization |
| 03/20/2008 | WO2008033175A2 Fabrication of heat-treated laminations for high-speed rotors in electrical machines |
| 03/20/2008 | WO2008032876A1 Preventive or remedy for er-negative and her2-negative breast cancer and method of screening the same |
| 03/20/2008 | WO2008032777A1 Antibacterial peptide and use thereof |
| 03/20/2008 | WO2008031899A2 Oligonucleotide non-viral delivery systems |
| 03/20/2008 | WO2008031854A2 Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells |
| 03/20/2008 | WO2008031842A1 Inhibitors of gpr87 for cancer therapy |
| 03/20/2008 | WO2008031331A1 A recombinant adenovirus target-oriented coexpressing human p53 and p53aip1 |
| 03/20/2008 | WO2007133571A3 Methods and compositions related to tr4 |
| 03/20/2008 | WO2007106404A3 Vaccine for viruses that cause persistent or latent infections |
| 03/20/2008 | WO2007053803A3 Antagonist of teb4 and methods of use |
| 03/20/2008 | WO2001030965A3 Methods of in vivo gene transfer using a sleeping beauty transposon system |
| 03/20/2008 | WO2001025398A3 Process for inducing functional tolerance to gene transfer products |
| 03/20/2008 | US20080071069 For delivering DNA/RNA into cells |
| 03/20/2008 | US20080071066 Heparin binding protein for use in controlling angiogenesis and as wound healing agent |
| 03/20/2008 | US20080071065 Fibroblast Growth Factor-Like Polypeptides |
| 03/20/2008 | US20080070858 Administering a natriuretic hormone peptide (NHP), or a nucleic acid sequence encoding NHP; respiratory system disorders |
| 03/20/2008 | US20080070855 Preventing post-operative neovascularization in ophthalmic tissue; administering bevacizumab |